title: Butyrate delivered by butyrylated starch increases distal colonic epithelial apoptosis in carcinogen-treated rats.
abstract: Animal studies show that increasing large bowel butyrate concentration through ingestion of butyrylated or resistant starches opposes carcinogen-induced tumorigenesis, which is consistent with population data linking greater fiber consumption with lowered colorectal cancer (CRC) risk. Butyrate has been shown to regulate the apoptotic response to DNA damage. This study examined the impact of increasing large bowel butyrate concentration by dietary butyrylated starch on the colonic epithelium of rats treated with the genotoxic carcinogen azoxymethane (AOM). Four groups of 10 male rats were fed AIN-93G based-diets containing either low amylose maize starch (LAMS), LAMS with 3% tributyrin, 10% high amylose maize starch (HAMS) or 10% butyrylated HAMS (HAMSB). HAMS and HAMSB starches were cooked by heating in water. After 4 weeks, rats were injected once with AOM and killed 6 h later. Rates of apoptosis and proliferation were measured in colonic epithelium. Short-chain fatty acid concentrations in large bowel digesta and hepatic portal venous plasma were higher in HAMSB than all other groups. Apoptotic rates in the distal colon were increased by HAMSB and correlated with luminal butyrate concentrations but cellular proliferation rates were unaffected by diet. The increase in apoptosis was most marked in the base and proliferative zone of the crypt. Regulation of luminal butyrate using HAMSB increases the rates of apoptotic deletion of DNA-damaged colonocytes. We propose this pro-apoptotic function of butyrate plays a major role reducing tumour formation in the AOM-treated rat and that these data support a potential protective role of butyrate in CRC.
authors.affiliation: Preventative Health National Research Flagship, Commonwealth Scientific and Industrial Research Organisation (CSIRO) Food and Nutritional Sciences, PO Box 10041, Adelaide BC, Adelaide, South Australia 5000, Australia. julie.clarke@csiro.au
authors.forename: Julie M
authors.initials: JM
authors.lastname: Clarke
authors.forename: Graeme P
authors.initials: GP
authors.lastname: Young
authors.forename: David L
authors.initials: DL
authors.lastname: Topping
authors.forename: Anthony R
authors.initials: AR
authors.lastname: Bird
authors.forename: Lynne
authors.initials: L
authors.lastname: Cobiac
authors.forename: Benjamin L
authors.initials: BL
authors.lastname: Scherer
authors.forename: Jessica G
authors.initials: JG
authors.lastname: Winkler
authors.forename: Trevor J
authors.initials: TJ
authors.lastname: Lockett
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000187:drug effects*; D001397:Azoxymethane; D002087:Butyrates / Q000494:pharmacology*; D053148:Caspase 3 / Q000502:physiology; D049109:Cell Proliferation / Q000187:drug effects; D003110:Colonic Neoplasms / Q000139:chemically induced / Q000473:pathology / Q000517:prevention & control*; D005232:Fatty Acids, Volatile / Q000097:blood; D007413:Intestinal Mucosa / Q000473:pathology; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D013213:Starch / Q000494:pharmacology*
chemical_list: D002087:Butyrates; D005232:Fatty Acids, Volatile; D013213:Starch; D053148:Caspase 3; D001397:Azoxymethane
references.citation: Am J Clin Nutr. 2011 Nov;94(5):1276-83
references.pmid: 21940597
references.citation: J Nutr. 1993 Nov;123(11):1939-51
references.pmid: 8229312
references.citation: Mol Nutr Food Res. 2005 Jun;49(6):571-84
references.pmid: 15864783
references.citation: Apoptosis. 2009 Feb;14(2):203-17
references.pmid: 19130237
references.citation: Physiol Rev. 2001 Jul;81(3):1031-64
references.pmid: 11427691
references.citation: Int J Cancer. 1995 Jan 27;60(3):400-6
references.pmid: 7829251
references.citation: Scand J Gastroenterol. 1991 Dec;26(12):1285-94
references.pmid: 1662408
references.citation: J Chromatogr B Biomed Appl. 1995 Feb 17;664(2):415-20
references.pmid: 7780595
references.citation: Am J Clin Nutr. 2007 Oct;86(4):1146-51
references.pmid: 17921395
references.citation: Nat Rev Mol Cell Biol. 2004 Sep;5(9):752-62
references.pmid: 15340382
references.citation: J Nutr. 2003 Nov;133(11):3523-8
references.pmid: 14608068
references.citation: Int J Cancer. 1993 Sep 30;55(3):498-505
references.pmid: 8397167
references.citation: Int J Oncol. 1996 Nov;9(5):1055-69
references.pmid: 21541613
references.citation: Br J Cancer. 1994 May;69(5):937-42
references.pmid: 8180027
references.citation: Carcinogenesis. 1997 Jun;18(6):1265-70
references.pmid: 9214612
references.citation: Am J Clin Nutr. 1976 Apr;29(4):417-27
references.pmid: 773166
references.citation: Carcinogenesis. 2008 Nov;29(11):2169-74
references.pmid: 18684730
references.citation: Gut. 2004 Nov;53(11):1701-9
references.pmid: 15479695
references.citation: J Gastrointest Surg. 2008 Oct;12(10):1773-81; discussion 1781-2
references.pmid: 18661192
references.citation: Cancer Biol Ther. 2007 Feb;6(2):253-8
references.pmid: 17218781
references.citation: Oncol Res. 2000;12(2):83-95
references.pmid: 11132927
references.citation: Nutr Metab (Lond). 2009 Mar 07;6:11
references.pmid: 19267935
references.citation: Br J Nutr. 2006 Aug;96(2):276-82
references.pmid: 16923221
references.citation: Bioessays. 2002 Jan;24(1):91-8
references.pmid: 11782954
references.citation: J Pathol. 2001 Oct;195(3):285-92
references.pmid: 11673824
references.citation: J Exp Zool. 1998 Dec 15;282(6):691-702
references.pmid: 9846381
references.citation: Carcinogenesis. 1997 Apr;18(4):721-30
references.pmid: 9111206
references.citation: Carcinogenesis. 2008 Nov;29(11):2190-4
references.pmid: 18701436
references.citation: Cell Growth Differ. 1997 May;8(5):523-32
references.pmid: 9149903
references.citation: Br J Nutr. 2008 Oct;100(4):711-21
references.pmid: 18279550
references.citation: Pharmacol Ther. 2009 Jan;121(1):29-40
references.pmid: 18992769
references.citation: Cancer Epidemiol Biomarkers Prev. 2000 Aug;9(8):819-26
references.pmid: 10952099
references.citation: Clin Nutr. 2009 Dec;28(6):657-61
references.pmid: 19523724
references.citation: Carcinogenesis. 1992 Dec;13(12):2305-12
references.pmid: 1473238
references.citation: Cancer Res. 2009 Apr 1;69(7):2826-32
references.pmid: 19276343
references.citation: Curr Pharm Des. 2003;9(4):347-58
references.pmid: 12570825
references.citation: Nutr Cancer. 1998;30(3):175-81
references.pmid: 9631487
references.citation: Mol Carcinog. 2006 Jun;45(6):443-6
references.pmid: 16652377
references.citation: J Nutr. 2002 Jul;132(7):1812-8
references.pmid: 12097652
references.citation: Carcinogenesis. 2003 Aug;24(8):1347-52
references.pmid: 12807738
references.citation: Gut. 1993 Mar;34(3):386-91
references.pmid: 8386131
references.citation: Br J Nutr. 2003 Oct;90(4):823-7
references.pmid: 13129452
references.citation: Lancet. 2001 Dec 1;358(9296):1833-4
references.pmid: 11741620
references.citation: Carcinogenesis. 2002 May;23(5):713-9
references.pmid: 12016142
references.citation: J Nutr. 2004 May;134(5):1193-6
references.pmid: 15113969
references.citation: Arch Biol (Liege). 1965;76(2):419-37
references.pmid: 5858819
references.citation: Nutr Cancer. 1996;25(2):129-35
references.pmid: 8710682
references.citation: J AOAC Int. 2004 May-Jun;87(3):775-86
references.pmid: 15287679